Cite
HARVARD Citation
Imyanitov, E. et al. (n.d.). 2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy. International journal of gynecological cancer. p. A310. [Online].